Company information & drug savings for Urovant Sciences medications

Urovant Sciences, now part of Sumitomo Pharma, developed urological treatments for overactive bladder and other conditions. The company created vibegron, a beta-3 adrenergic agonist for overactive bladder with urinary incontinence, urgency, and frequency. Urovant’s urology expertise continues through Sumitomo Pharma’s portfolio.